NCT03132155 2024-05-24QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell SarcomaNantPharma, LLCPhase 2 Terminated8 enrolled 10 charts
NCT03147976 2019-08-28QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid TumorsNantPharma, LLCPhase 2 Withdrawn
NCT02016534 2017-07-02Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid TumorsAmgenPhase 2 Terminated60 enrolled